Fig. 6From: Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological studyComparison of surrogate-based effect estimates from pivotal trials and post approval trials. One outlier not show on graphBack to article page